Mankind Pharma P/B Ratio
Mankind Pharma (MANKIND) P/B ratio is 5.69 (High), book value per share ₹4039.27 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore MANKIND true value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MANKIND P/B Ratio — Valuation Insights & Book Value Analysis
Mankind Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 5.69 (High). For live price, earnings yield and the full fundamental profile, see MANKIND share price screener.
- Stock appears overvalued with PB of 5.69, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 563.6% above historical average
- Trading at premium to sector average PB of -0.01
Mankind Pharma P/B Ratio Historical Trend
MANKIND annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read MANKIND dividend payout details for the complete payout history and dividend yield track record.
MANKIND Historical P/B Ratio — Book Value Per Share & Year-End Price
Mankind Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.57 | ₹4039.27 | ₹2300.70 | ₹16,561 | Low |
| 2025 | 0.62 | ₹3553.17 | ₹2196.50 | ₹14,568 | Low |
| 2024 | 1.2 | ₹2394.0 | ₹2880.40 | ₹9,576 | Moderate |
| 2023 | 1.04 | ₹1905.75 | ₹1982.50 | ₹7,623 | Moderate |
MANKIND vs Healthcare Peers — P/B Ratio Comparison
Mankind Pharma P/B 5.69 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |